Rozanolixizumab
Catalogue number:
HY-P9979-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
TNF Receptor
Alternative Names:
UCB7665
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].